The Hit ID Summit 2025 presents a prime opportunity to forge new and strengthen existing relationships with key decision-makers actively seeking innovative tools and technologies to enhance drug discovery. By supporting leading large pharmaceutical and biotech companies in tackling increasingly complex targets, you can showcase your expertise in flexible and customizable hit identification. This capability is essential for overcoming challenges with difficult targets such as intrinsically disordered proteins and PROTACs.
Highlight your high-quality screening compounds and custom libraries, demonstrating your ability to support a range of modalities. Additionally, emphasize your cutting-edge instrumentation, data management, and AI solutions, which are crucial for managing large-scale data and ensuring successful drug discovery processes.
Join us in 2025 to gain visibility among top industry professionals and contribute to the advancement of early drug discovery, from Target Identification and Validation to Hit Identification, Lead Selection, and Optimization. Together, we can drive the future of drug discovery and solidify your position as a leader in this critical field.
Why Partner in 2025?
Build Trust:
Establish yourself as a thought leader and a crucial partner by showcasing your hit identification expertise and building credibility
Generate Leads:
Engage in face-to-face interactions with key drug discovery decision makers during speed networking sessions, creating valuable connections and opportunities
Gain Insights:
Obtain valuable market insights into new screening strategies, and forge meaningful relationships to refine your strategies and accelerate your business growth
